SAVA vs. ALZN

In the year-to-date period, SAVA achieves a 14.41% return, which is significantly higher than ALZN's -12.07% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Cassava Sciences, Inc. (SAVA) and Alzamend Neuro, Inc. (ALZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current SAVA Sharpe Ratio is -0.63, which is lower than the ALZN Sharpe Ratio of -0.42. The chart below compares the historical Sharpe Ratios of SAVA and ALZN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither SAVA nor ALZN has paid dividends to shareholders.

The maximum SAVA drawdown since its inception was -99.18%, roughly equal to the maximum ALZN drawdown of -99.95%. Use the drawdown chart below to compare losses from any high point for SAVA and ALZN. For additional features, visit the drawdowns tool.

Cassava Sciences, Inc. (SAVA) has a higher volatility of 14.49% compared to Alzamend Neuro, Inc. (ALZN) at 10.47%. This indicates that SAVA's price experiences larger fluctuations and is considered to be riskier than ALZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Cassava Sciences, Inc. and Alzamend Neuro, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.